Cargando…

Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy

BACKGROUND: accurate prognostic prediction is challenging for advanced-stage non-small cell lung cancer (NSCLC) patients. METHODS: we systematically investigated genetic variants within inflammation pathway as potential prognostic markers for advanced-stage NSCLC patients treated with first-line che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Xia, Hildebrandt, Michelle A., Lu, Charles, Roth, Jack A., Stewart, David J., Zhao, Yang, Heist, Rebecca S., Ye, Yuanqing, Chang, David W., Su, Li, Minna, John D., Lippman, Scott M., Spitz, Margaret R., Christiani, David C., Wu, Xifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141040/ https://www.ncbi.nlm.nih.gov/pubmed/24755914 http://dx.doi.org/10.1038/clpt.2014.89

Ejemplares similares

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2010)

Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2015)

Inflammation-related genetic variants predict toxicities following definitive-radiotherapy for lung cancer
por: Pu, Xia, et al.
Publicado: (2014)

MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer
por: Li, Rong, et al.
Publicado: (2016)

Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients
por: Pierzynski, Jeanne A., et al.
Publicado: (2018)

Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer
por: Lin, Moubin, et al.
Publicado: (2017)

Wnt Signaling Pathway Pharmacogenetics in Non-Small Cell Lung Cancer
por: Stewart, David J., et al.
Publicado: (2014)

Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer
por: Dai, Jingyao, et al.
Publicado: (2011)

Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy
por: Guo, Guifang, et al.
Publicado: (2019)

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.
por: Kelsey, K. T., et al.
Publicado: (1997)

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
por: Wu, Xifeng, et al.
Publicado: (2016)

Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
por: Wu, Xifeng, et al.
Publicado: (2020)

The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen
por: Geng, Nan, et al.
Publicado: (2021)

Effects of Exercise on Inflammation in Patients Receiving Chemotherapy: A Nationwide NCORP Randomized Clinical Trial
por: Kleckner, Ian R., et al.
Publicado: (2019)

Calculus of Variations and Partial Differential Equations
por: Hildebrandt, Stefan, et al.
Publicado: (1988)

Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
por: Wang, Zhuo, et al.
Publicado: (2020)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
por: Pataer, Apar, et al.
Publicado: (2018)

Variation in the use of chemotherapy in lung cancer
por: Patel, N, et al.
Publicado: (2007)

Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy
por: Zhang, Liqun, et al.
Publicado: (2020)

The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy
por: Cheng, Jie, et al.
Publicado: (2022)

Dynamic impact of inﬂammation-based indices in colorectal cancer patients receiving FOLFOX-based chemotherapy
por: Tao, Yong, et al.
Publicado: (2019)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Idiosyncratic and dose-dependent epistasis drives variation in tomato fruit size
por: Aguirre, Lyndsey, et al.
Publicado: (2023)

Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S.
por: Tu, Huakang, et al.
Publicado: (2016)

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
por: Hackshaw, A, et al.
Publicado: (2005)

The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
por: Zhou, Ting, et al.
Publicado: (2015)

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
por: Duan, Xiao-Peng, et al.
Publicado: (2023)

Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk
por: Wang, Jian, et al.
Publicado: (2012)

Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk
por: Wei, Hua, et al.
Publicado: (2012)

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Plasmodium falciparum Sexual Commitment Rate Variation among Clinical Isolates and Diverse Laboratory-Adapted Lines
por: Stewart, Lindsay B., et al.
Publicado: (2022)

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Chemotherapy administration checklist for patients receiving chemotherapy: Development and validation
por: Miglani, Gitika, et al.
Publicado: (2022)

Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019)

Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
por: Markus, M., et al.
Publicado: (2020)

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

A Public Health Perspective on Preventing and Controlling the Spread of Coronavirus Disease 2019
por: Wu, Xifeng, et al.
Publicado: (2020)

Pedometer-based Exercise Interventions for Patients with Breast Cancer Receiving Chemotherapy – A Systematic Review
por: Samuel, Stephen Rajan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g0tl5thlq0osaqme26tnpg7ttj